BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 14567913)

  • 41. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
    Kato M; Patel MS; Levasseur R; Lobov I; Chang BH; Glass DA; Hartmann C; Li L; Hwang TH; Brayton CF; Lang RA; Karsenty G; Chan L
    J Cell Biol; 2002 Apr; 157(2):303-14. PubMed ID: 11956231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.
    Kaji H; Kanatani M; Sugimoto T; Chihara K
    Horm Metab Res; 2005 Oct; 37(10):589-92. PubMed ID: 16278780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
    Redlich K; Görtz B; Hayer S; Zwerina J; Doerr N; Kostenuik P; Bergmeister H; Kollias G; Steiner G; Smolen JS; Schett G
    Am J Pathol; 2004 Feb; 164(2):543-55. PubMed ID: 14742260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment?
    Coetzee M; Kruger MC
    South Med J; 2004 May; 97(5):506-11. PubMed ID: 15180028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in osteoclast biology and pathological bone resorption.
    Blair HC; Athanasou NA
    Histol Histopathol; 2004 Jan; 19(1):189-99. PubMed ID: 14702187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyrotropin, Hyperthyroidism, and Bone Mass.
    Kim SM; Ryu V; Miyashita S; Korkmaz F; Lizneva D; Gera S; Latif R; Davies TF; Iqbal J; Yuen T; Zaidi M
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4809-e4821. PubMed ID: 34318885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
    Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
    Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
    J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
    Siddiqui JA; Swarnkar G; Sharan K; Chakravarti B; Sharma G; Rawat P; Kumar M; Khan FM; Pierroz D; Maurya R; Chattopadhyay N
    Mol Cell Endocrinol; 2010 Jul; 323(2):256-67. PubMed ID: 20380869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.
    Tsukii K; Shima N; Mochizuki S; Yamaguchi K; Kinosaki M; Yano K; Shibata O; Udagawa N; Yasuda H; Suda T; Higashio K
    Biochem Biophys Res Commun; 1998 May; 246(2):337-41. PubMed ID: 9610359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
    Karieb S; Fox SW
    Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.
    Boutin A; Eliseeva E; Gershengorn MC; Neumann S
    FASEB J; 2014 Aug; 28(8):3446-55. PubMed ID: 24723693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge.
    Kim HH; Kim JH; Kwak HB; Huang H; Han SH; Ha H; Lee SW; Woo ER; Lee ZH
    Biochem Pharmacol; 2004 May; 67(9):1647-56. PubMed ID: 15081864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.